APA (7th ed.) Citation

JP, F., M, P., J, B., F, V., P, M., S, P., . . . SD, A. (2026). Serum Magnesium, Outcomes, and the Effect of Empagliflozin in Heart Failure With Mildly Reduced and Preserved Ejection Fraction: Findings From EMPEROR-Preserved. JACC. Heart failure, 14(2), 102889. https://doi.org/10.1016/j.jchf.2025.102889

Chicago Style (17th ed.) Citation

JP, Ferreira, Packer M, Butler J, Vasques-Nóvoa F, Marques P, Pocock S, Filippatos G, Zannad F, and Anker SD. "Serum Magnesium, Outcomes, and the Effect of Empagliflozin in Heart Failure With Mildly Reduced and Preserved Ejection Fraction: Findings From EMPEROR-Preserved." JACC. Heart Failure 14, no. 2 (2026): 102889. https://doi.org/10.1016/j.jchf.2025.102889.

MLA (9th ed.) Citation

JP, Ferreira, et al. "Serum Magnesium, Outcomes, and the Effect of Empagliflozin in Heart Failure With Mildly Reduced and Preserved Ejection Fraction: Findings From EMPEROR-Preserved." JACC. Heart Failure, vol. 14, no. 2, 2026, p. 102889, https://doi.org/10.1016/j.jchf.2025.102889.